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Abstract
Background: Luteinizing hormone-releasing hormone (LHRH) is an exogenous hormone commonly used to
induce spermiation in anuran amphibians. Over the past few decades, the LHRH dose administered to individuals
and the frequency of injection has been highly variable. The sperm-release responses reported have been
correspondingly diverse, highlighting a need to quantify dose-response relationships on a species-specific basis.
This study on the Australian anuran Pseudophryne guentheri first evaluated the spermiation response of males
administered one of five LHRHa doses, and second, determined whether AVT administered in combination with
the optimal LHRHa dose improved sperm-release.
Methods: Male toadlets were administered a single dose of 0, 1, 2, 4 or 8 micrograms/g body weight of LHRHa. A
4 micrograms/g dose of AVT was administered alone or in combination with 2 micrograms/g LHRHa. Spermiation
responses were evaluated at 3, 7 and 12 h post hormone administration (PA), and sperm number and viability
were quantified using fluorescent microscopy.
Results: LHRHa administration was highly effective at inducing spermiation in P. guentheri, with 100% of hormone-
treated males producing sperm during the experimental period. The number of sperm released in response to 2
micrograms/g LHRHa was greater than all other doses administered and sperm viability was highest in the 1
microgram/g treatment. The administration of AVT alone or in combination with LHRHa resulted in the release of
significantly lower sperm numbers.
Conclusion: Overall, results from this study suggest that in P. guentheri, LHRHa is effective at inducing spermiation,
but that AVT inhibits sperm-release.
Background
Amphibian populations are declining worldwide at a
rate unparalleled by any other vertebrate group [1]. In
an attempt to impede this unprecedented loss of amphi-
bians, captive assurance colonies are being established
for threatened and endangered species. Unfortunately
breeding failures are common due to the inherent diffi-
culties associated with simulating the specific environ-
mental conditions required to trigger anurans to breed
in captivity [2]. As a result, captive breeding facilities
are now focusing their attention to assisted reproductive
technologies (ART) [2].
An integral component of assisted reproduction is the
reliable and effective collection of spermatozoa for cryo-
preservation and artificial fertilisation (AF). Tradition-
ally, collection of anuran spermatozoa has been
facilitated by the removal and maceration of testes from
euthanized individuals [3]. This method has been widely
used because of the ease and reliability at which high
concentrations of spermatozoa can be obtained, but
research in reproductive biology is now favouring the
u s eo fn o n - i n v a s i v et e c h n i q u e st h a tc a nb ea p p l i e dt o
live individuals [4]. Exogenous hormones have been Correspondence: Aimee.Silla@gmx.com
School of Animal Biology, The University of Western Australia, Perth, Australia
Silla Reproductive Biology and Endocrinology 2010, 8:139
http://www.rbej.com/content/8/1/139
© 2010 Silla; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.used to induce spermiation (sperm release) in a number
of anuran [5-11] and urodele [10,12,13] species since
the early 20
th century. One of the hormones more com-
monly used to induce spermiation is luteinizing hor-
mone-releasing hormone (LHRH). LHRH is a tropic
peptide hormone that stimulates the anterior pituitary
gland to release luteinizing hormone (LH). If a sufficient
dose of LHRH is administered it will trigger the acute
rise in LH necessary to stimulate spermiation. Although
LHRH has been used to induce spermiation over the
past few decades the dose applied to individuals, as well
as the method and frequency of LHRH administration,
has been highly variable [14]. The resultant spermiation
responses have been correspondingly diverse, highlight-
ing a need to quantify dose-response relationships.
Amphibian species appear to vary considerably in their
sensitivity to LHRH administration, despite the conser-
vation of the structure and function of LHRH among
vertebrates. Goncharov et al. [10] induced 39 amphibian
species to spawn following administration of a synthetic
LHRH analogue, but the concentration of LHRHa
required was highly variable. In some species, indivi-
duals could be induced to spawn following a single
injection of 0.0002 μg/g, while others required repeated
injections in excess of 0.8 μg/g, representing a 4000-fold
range in LHRHa potency. In response to the observed
variation in spermiation responses, Kouba et al. [2]
recently recognised an urgent need to develop dose-
response curves on a species-specific basis as opposed
to the trial-and-error approaches commonly used by
zoological institutions.
If doses of LHRH administered are too low for a given
species, they will induce LHRH-receptor synthesis (up-
regulation) without a change in serum or pituitary
LH content [15,16]. As the LHRH dose administered
increases, nearing the optimal concentration, up-regula-
tion of LHRH receptors continues, receptor numbers
are elevated and the tissue responds with an LH surge
[16] inducing an increasingly positive spermiation
response. Where LHRH doses administered are above
the optimal concentration for a species, pituitary desen-
sitization and/or down-regulation of LHRH-receptors
occurs, reducing LH release and impeding the spermia-
tion response [15]. Administration of extreme supraphy-
siological doses further leads to the down-regulation of
LHRH-receptors at both the pituitary and gonadal levels,
blocking testis activation and inducing temporary anti-
fertility effects [15].
In addition to a need to identify optimal LHRH
doses, there is a growing interest in trialling the use of
combinations of hormones to improve the efficacy of
gamete-release induction protocols [17,18]. The neuro-
hypophysial peptide arginine vasotocin (AVT) has long
been recognised for its role in the reproductive
behaviours of amphibians such as male and female
vocalization [19,20], pheromone release [21] and
amplectic clasping [22,23]. Additionally AVT has been
shown to induce smooth muscle contractions of the
oviduct [24,25] and has subsequently been used to
induce partuition and oviposition in a number of
amphibian and reptile species [23,26]. Zoeller et al [27]
were the first to propose a link between AVT and the
transport of spermatozoa into the cloaca in amphi-
bians, having successfully elicited contraction of the
Wolffian ducts in the rough-skinned newt (Taricha
granulosa) in vitro. In support of these findings, a
study of the red-bellied newt (Cynops pyrrhogaster)
quantified a dose-dependent induction of spermato-
phore deposition to administration of AVT in vivo
[21]. Based on these results, it is hypothesised that
AVT will enhance the timing and/or the number of
spermatozoa released in anuran amphibians.
To address the lack of dose-response data and to
investigate the possible synergy of simultaneous admin-
istration of LHRHa and AVT, this study used the Wes-
tern Australian anuran Pseudophryne guentheri,t o :1 )
evaluate the dose-response relationship of changes in
sperm count, sperm viability and timing of sperm
release in response to LHRHa administration; and 2)
determine whether AVT administered in combination
with the optimal LHRHa dose alters the sperm-release
response.
Methods
The procedures described in this manuscript were con-
ducted following evaluation and approval by the Univer-
sity of Western Australia’s Animal Ethics Committee
(approval number RA/3/100/869).
Study species
Pseudophryne guentheri is a small (26-33 mm, snout-
vent length) stout-bodied toadlet (family: Myobatrachi-
dae) endemic to south Western Australia. The breeding
season of this species is prolonged, commencing in
autumn following heavy rainfall and continuing for sev-
eral weeks. Male P. guentheri aggregate in low lying
areas that are subject to seasonal inundation where they
construct and defend terrestrial burrows. To attract
mates, male P. guentheri produce advertisement calls
that are broadcast from the entrance of the burrow. Fol-
lowing successful courtship, which takes place below the
soil surface, females deposit a small clutch of eggs
(range = 80-410, mean = 224 ± 12, n = 40, Silla unpub-
lished data). The developing embryos remain encapsu-
lated until the burrow floods in winter triggering the
tadpoles to hatch into temporary pools where they com-
plete development. This reproductive mode (terrestrial
embryonic development, aquatic larvae) is consistent
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cies in the genus Pseudophryne [28].
Study site and animal collection
Male P. guentheri were collected from a breeding chorus
located in the Pinjar Wetlands, approximately 40 km
north of Perth, Western Australia. All collections took
place between 18:00 and 24:00 hours from June 1-19
2009. Terrestrial nests were located by triangulating
male vocalisations and the resident toadlets were col-
lected by hand. The toadlets were identified as mature
males from their calling behaviour and the presence of
pigmented vocal sacs. Within four hours of collection,
males were transported to a constant temperature room
set to a 17°C day/12°C night temperature cycle and
maintained under artificial illumination (10.5 h light/
13.5 h dark). Animals were housed individually in plastic
aquaria (220 mm L × 140 mm W × 160 mm H) con-
taining a layer of moist sponge beneath 10-12 cm of
soil, which allowed males to burrow for shelter. Toadlets
were randomly assigned to one of seven treatment
groups (see ‘hormone administration’ section below) and
there were no significant differences (ANOVA: F6, 63 =
1.49, p= 0.20) in the size of animals between treatments
(n = 64, average mass = 2.79 ± 0.04 SEM). An ‘acclima-
tion period’ of 4-6 days was allowed before experiments
commenced in order to minimise potential effects of
collection stress, and elevated corticosterone levels, on
the efficacy of hormone treatment.
Hormone administration
This experiment was conducted in two stages; the first
involved establishing a spermiation dose-response rela-
tionship to four doses of LHRHa (see ‘stage one’ below)
and the second stage tested the ability of AVT (see
‘stage two’ below), administered in combination with the
optimal dose of LHRHa (as identified in stage one), to
improve sperm release. The experiment was conducted
from 6/6/09 to 1/7/09 with an interval of 6 days
between stage one and two.
Stage one: Effect of LHRHa dose on spermiation
response- The spermiation response of male P. guentheri
administered a single dose of 1 μg, 2 μg, 4 μgo r8μg/g
body weight LHRHa (Leuprorelin acetate; Lucrin®) was
quantified. Hormones were diluted in 100 μL of Simpli-
fied Amphibian Ringer (113 mM NaCl, 2 mM KCl, 1.35
mM CaCl2,1 . 2m MN a H C O 3) and administered to
males via subcutaneous injection into the dorsal lymph
sac. A control treatment consisted of toadlets adminis-
tered 100 μL of Simplified Amphibian Ringer (SAR), the
vehicle for hormone administration. The experimental
treatments and the control treatment all involved a sam-
ple size of 10 toadlets. Immediately prior to hormone
application, P. guentheri were weighed to the nearest
0.01 g and the dose administered was adjusted accord-
ing to an individual’s body mass.
Stage two: Effect of LHRHa and AVT on spermiation
response- To determine the effect of administering
LHRHa (Leuprorelin acetate; Lucrin®) in combination
with AVT (arg
8- vasotocin acetate salt; Sigma-Aldrich)
on the sperm-release response of P. guentheri the opti-
mal LHRHa dose (as identified by stage one above) was
administered in combination with 4 μg/g AVT (n = 7).
An additional 7 males received 4 μg/g AVT in the
absence of LHRHa as a positive control. Hormones
were diluted in 100 μL of SAR and injected into the
toadlet’s dorsal lymph sac as described above.
Following hormone administration all individuals were
returned to separate plastic holding tanks (50 mm D ×
90 mm H) containing three pieces of moist sponge (20
mm W × 20 mm L × 3 mm H). Adopting this proce-
dure ensured sufficient hydration of the males to permit
the collection of urine throughout the sampling period.
To minimise faecal contamination of the urine samples,
toadlets were not fed during the four days prior to
experimentation.
Collection and assessment of spermic urine
Spermic urine samples were collected at 3, 7 & 12 h
(± 10 mins) after hormone administration. The collec-
tion method involved placingt h ee n do fag l a s sm i c r o -
capillary tube (fire polished and cooled) into the cloaca
and massaging the walls of the cloacal opening with the
tube until urination occurred. Once collected, spermic
urine volume was measured by placing the microcapil-
lary tube alongside a ruler and the sample was then pre-
pared for assessment of sperm yield and sperm viability
using fluorescent microscopy. Spermic urine was homo-
genized with 5 μL of a 1:50 dilution of the nucleic acid
stain SYBR-14 (Invitrogen L-7011) and incubated in the
dark for 7 min. A 2 μL aliquot of Propidium iodide was
added and the solution was incubated in the dark for a
further 7 min. A wet mount was prepared and sperm
viability evaluated by fluorescent microscopy under
x20 magnification at a wavelength of 490 nm. Spermato-
zoa fluorescing bright green were considered viable,
while those exhibiting red fluorescence were considered
non-viable [29]. The total sperm count and proportion
of viable sperm per sample was quantified for the abso-
lute volume of urine collected for each sample.
Statistical analyses
The number of spermiating toadlets was compared
between LHRHa dose treatments (1 μg/g, 2 μg/g, 4 μg/g
or 8 μg/g), and between each dose treatment and the
control, using two-tailed Fisher exact tests. The number
of spermatozoa expelled and sperm viability were com-
pared between treatments using one-way analysis of
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cant Difference (HSD) post hoc tests. Bartlett’st e s t s
were conducted on all variables to determine homoge-
neity of variances prior to all other analyses. Data on
the number of spermatozoa expelled were log trans-
formed, using the transformation log10(x+1) and sperm
viability data was arcsine transformed using the transfor-
mation sin
-1(√x). Comparison of the number of sperma-
tozoa expelled at 7 h and 12 h were analysed using
Welch’s ANOVAs due to unequal variances after trans-
formation. All statistical analyses were performed using
the JMP 8.0.1 software package (SAS Institute Inc.
2009). For all tests in this study, P < 0.05 was consid-
ered significant.
Results
Effect of LHRHa dose on spermiation response
Urine samples were successfully collected from all indi-
viduals at each sampling period (3, 7 & 12 h) post
administration (PA), with urine volumes ranging from 2
-152 μL (mean = 21.29 ± 1.59 μL). Of the urine samples
obtained from males administered 1 μg/g, 2 μg/g, 4 μg/g
or 8 μg/g LHRHa, 90-100% contained spermatozoa
within 3 h PA (figure 1A). The number of spermiating
males further increased at subsequent sampling periods,
such that 100% of individuals in each of the four dose
treatments (1 μg/g, 2 μg/g, 4 μg/g or 8 μg/g) were
responsive at 7 h and 12 h PA (figure 1 B &1C). The
majority of samples obtained from control animals were
aspermic, however 10-30% of individuals within this
treatment released spermatozoa at each sampling period
(figure 1). The number of spermiating males was signifi-
cantly higher in hormone treatments relative to the con-
trol treatment, but the number of spermiating males
administered varying doses of LHRHa (1 μg/g, 2 μg/g,
4 μg/g or 8 μg/g) did not differ significantly from one
another (Tab. 1).
The total number of spermatozoa expelled over a 12 h
period PA differed significantly according to dose treat-
ment (one-way ANOVA, F4,49 = 43.16, p < 0.001; figure 2).
The 2 μg/g treatment produced a significantly higher
number of spermatozoa compared to the control and
8 μg/g treatments (Tukey-Kramer HSD, P < 0.05; figure 2),
but was not significantly higher than to the 1 μg/g or 4
μg/g treatments (Tukey-Kramer HSD, P > 0.05; figure
2). In addition to the treatment effect identified for the
total spermatozoa expelled, significant treatment effects
were also detected at each of the individual sampling
times, 3 h (one-way ANOVA, F4,49 = 13.22, p <0 . 0 0 1 ) ,
7 h (Welch’sA N O V A ,F 4 = 132.32, p < 0.001) and 12 h
(Welch’sA N O V A ,F 4 =7 4 . 6 4 ,p < 0.001) PA. The num-
ber of spermatozoa expelled by males in the 2 μg/g
treatment was consistently higher than the remaining
treatments at all sampling periods PA (Tab. 2). Peak
sperm-release occurred at 7 h PA for males adminis-
tered 8 μg/g LHRHa, while all remaining dose treat-
ments produced the highest number of spermatozoa at
12 h PA (Tab. 2). The total number of spermatozoa
expelled was not related to the volume of urine col-
lected or to toadlet mass (r
2 =0 . 0 0 3 ,p = 0.724; r
2 =
0.008, p = 0.549, respectively).
The proportion of viable sperm (sperm viability) was
calculated for all samples where a sperm count of ≥30
spermatozoa was achieved. The overall mean sperm via-
bility differed significantly according to dose treatment
(one-way ANOVA, F3,38 = 3.07, p = 0.040), with toadlets
injected with 1 μg/g producing spermic urine samples of
significantly higher sperm viability than those adminis-
tered 8 μg/g LHRHa (0.667 ± 0.045 vs 0.489 ± 0.036;
Tukey-Kramer HSD, P < 0.05). Males within the 2 μg/g
and 4 μg/g treatments produced spermic urine samples
of intermediate sperm viability which were not signifi-
cantly different from any of the remaining treatments
(0.524 ± 0.047; 0.605 ± 0.054, respectively; Tukey-
Kramer HSD, P > 0.05). The temporal effect of sampling
period (3, 7 & 12 h) on sperm viability did not affect the
dose treatments consistently. The sperm viability of
samples collected from toadlets in the 4ug/g and 8ug/g
treatments decreased over time, while the sperm viabi-
lity of spermic urine samples collected from males in
the 1ug/g treatment increased with increasing time PA
(Tab. 3). The sperm viability of samples in the 2ug/g
treatment decreased slightly at 7 h PA before increasing
again at 12 h PA (Tab. 2).
Effect of LHRHa and AVT on spermiation response
The number of male toadlets spermiating in response to
the administration of 2ug/g LHRHa (10/10 males) was
not significantly different to the number of spermiating
males administered either 4ug/g AVT (5/7 males) or the
combination of 2ug/g LHRHa +4ug/g AVT (5/7 males)
(two-tailed Fisher Exact Tests, p > 0.05). In contrast, the
difference in the number of spermatozoa expelled from
males across these three treatments was highly signifi-
cant (one-way ANOVA, F2,23 = 38.865, p <0 . 0 0 1 ) .T h e
2 μg/g treatment produced significantly greater sperm
counts than the AVT and AVT + LHRHa treatments
(Tukey-Kramer HSD, P < 0.05; figure 3), which both
yielded mean sperm counts of less than 100 spermato-
zoa. The viability of spermatozoa collected from toadlets
administered LHRHa, AVT and LHRHa+AVT (0.524 ±
0.047; 0.453 ± 0.216; 0.560 ± 0.200, respectively) did
not differ significantly (one-way ANOVA, F2,14 = 0.144,
p = 0.868).
Discussion
To date, studies investigating the hormonal induction of
spermiation in amphibians in vivo have largely failed to
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variation of hormone potency observed between species.
This study quantified the sperm count, sperm viability
and timing of sperm release of P. guentheri in response
to five doses of LHRHa, and also determined whether
AVT administered in combination with the optimal
dose of LHRHa improved the sperm-release response.
Effect of LHRHa dose on spermiation response
The results of this study showed that administration of
LHRHa at doses between 1 μg- 8 μg/g body weight
were highly successful at inducing P. guentheri to
spermiate. Between 90 and 100% of males released sper-
matozoa within 3 h of treatment, and 100% of males
released spermatozoa at 7 and 12 h PA. The number of
spermiating males did not differ according to dose
administered, but as expected, the number of spermato-
zoa expelled between dose treatments varied signifi-
cantly. Peak sperm release occurred in the 2 μg/g
treatment, with a large drop in the number of spermato-
zoa expelled in the 4 μg/g treatment, and a further
decline identified in the 8 μg/g treatment. This reduc-
tion in the number of spermatozoa expelled in the
higher dose treatments could be a result of LHRH-
receptor down-regulation, where LHRH doses above
optimal levels induce a decline in the number of LHRH-
receptors, reducing LH release, and subsequently imped-
ing the spermiation response [15]. Results from this
experiment indicate that studies attempting to induce
spermiation in P. guentheri might avoid pituitary desen-
sitization and/or LHRH-receptor down regulation by
administering LHRH at doses below 4 μg/g.
Concentrations of synthetic LHRHa administered to
induce spermiation in anurans are highly variable, but
typically do not exceed 0.8 μg/g per injection
[7,10,30,31]. For example, in the South American frog,
Lepidobatrachus laevis a dose range of 0.288-0.579 μg/g
induced the release of an average of 6.2 × 10
6 spermato-
zoa per male [30]. Similarly, a recent study in the
Australian hylid Litoria peronii successfully induced
s p e r m i a t i o nb ya d m i n i s t e r i n gad o s eo f0 . 7 5μg/g
LHRHa [31]. The optimal dose identified in this study
was substantially higher (2 μg/g). This result may be a
consequence of P. guentheri being less sensitive to
LHRHa than the majority of previous anuran species
studied. Alternatively, given the current lack of empirical
dose-response studies in anurans, coupled with high
spermiation failure rates for many species, it may be
that the LHRHa doses typically used to induce spermia-
tion in anurans are sub-optimal.
With respect to sperm viability, analysis of spermic
urine samples revealed that the 1 μg/g treatment pro-
duced a higher proportion of live sperm than the 8 μg/g
treatment, suggesting that lower LHRHa doses induce
the release of higher quality spermatozoa in this species.
Overall, average sperm viability ranged from 48.9% to
66.7% between dose treatments. This range is consider-
ably lower than the > 84% reported by Rowson et al.
[14] for Bufo americanus and B. valliceps and the 97.5%
and 95.3% reported by Obringer et al. [7] for B. ameri-
canus and B. baxter. The highest sperm viability
reported in the present study was also at the lower end
of the range of 58% to 97% reported by for the Austra-
lian hylid Litoria peronii [31].
Sperm viability is an important indicator of the ferti-
lizing capacity of spermatozoa. Obtaining spermatozoa
Table 1 Comparison of the number of spermiating males administered LHRHa (n = spermiating toadlets/toadlets
within treatment group)
Control (n = 4/10) 1 μg/g (n = 10/10) 2 μg/g (n = 10/10) 4 μg/g (n = 10/10) 8 μg/g (n = 10/10)
Control (n = 4/10) 0.011* 0.011* 0.011* 0.011*
1 μg/g (n = 10/10) 0.011* 1.000 1.000 1.000
2 μg/g (n = 10/10) 0.011* 1.000 1.000 1.000
4 μg/g (n = 10/10) 0.011* 1.000 1.000 1.000
8 μg/g (n=10/10) 0.011* 1.000 1.000 1.000
Data shown are P values generated from two-tailed Fisher Exact Tests. * denotes statistical significance (P < 0.05).
Figure 2 Total number of spermatozoa (× 10
3) released by
males administered LHRHa (n = 10) over a 12 h sampling
period. Data shown are untransformed mean ± SEM. Letters
displayed are the result of a Tukey Kramer HSD post-hoc test of
Log10 (x +1) transformed data. Treatments that share a letter are not
significantly different from each other.
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toward successful artificial fertilizations, and should be
the focus of future ART research in P. guentheri.T h e
comparatively low sperm viability reported in this study
may be due to two factors. First, it may be an artefact of
the sampling intervals employed and the latency period
during which spermatozoa remained in the cloaca after
spermiation. Spermatozoa released within minutes of
the sampling period may remain viable, whereas those
spermatozoa released hours earlier may not survive a
prolonged period in the cloaca. This would be reflected
by a moderate to poor sperm viability overall, and may
be avoided by reducing the sampling period to hourly or
half-hourly intervals. Alternatively, reduced sperm viabi-
lity may be a reflection of incomplete spermatogenesis
and capacitation of spermatozoa prior to spermiation.
This may be elucidated in future studies by examining
histological sections of the testes.
Incomplete gamete maturation may be improved by
altering hormone administration protocols. For example,
aquaculture research has long acknowledged the bene-
ficial effect of multiple hormone injections and
controlled-release delivery systems on broodstock
spawning (for a review see [32]). These methods of pul-
satile hormone administration may work to ‘prime’ the
hypothalamic-pituitary-gonadal axis, promoting gameto-
genesis and final gamete maturation prior to gamete
release. In the Wyoming Toad, Bufo baxteri multiple
low-dose priming injections administered prior to a
higher ovulatory dose have been successful in promoting
the ovulation of more oocytes of better quality [8]. Low
dose priming protocols may similarly improve spermia-
tion in male anurans, but are yet to be empirically
tested.
Another method used to improve gamete release in
lower vertebrates is the administration of dopamine
antagonists (e.g., domperidone, pimozide, reserpine or
metoclopramide) prior to, or in combination with, the
administration of LHRHa [17,18,32,33]. Dopamine inhi-
b i t st h er e l e a s eo fg o n a d o t r o p i n sf r o mt h ep i t u i t a r y ,
reducing the stimulatory effect of LHRHa on LH release
[32]. Dopamine antagonists are therefore used to pre-
vent the release of dopamine or inhibit its binding in
order to enhance the LHRHa-induced release of viable
Table 2 The number of spermatozoa released (× 10
3) and sperm viability of samples collected at 3, 7 and 12 h post
LHRHa administration
3 h PA 7 h PA 12 h PA
Treatment Sperm Count (× 10
3) Sperm Viability Sperm Count (× 10
3) Sperm Viability Sperm Count (× 10
3) Sperm Viability
Control 0.002 ± 0.002 - 0.0002 ± 0.0002 - 0.0009 ± 0.0009 -
1 μg/g 2 .79 ± 1 .57 0.62 ± 0.09 3 .36 ± 1 .55 0.67 ± 0.05 15 .54 ± 2 .41 0.71 ± 0.07
2 μg/g 6 .07 ± 2 .06 0.56 ± 0.05 5 .04 ± 2 .27 0.48 ± 0.08 13 .69 ± 6 .27 0.54 ± 0.06
4 μg/g 0 .66 ± 0 .33 0.66 ± 0.10 3 .20 ± 1 .47 0.62 ± 0.06 14 .29 ± 2 .38 0.57 ± 0.08
8 μg/g 0 .87 ± 0 .64 0.64 ± 0.09 2 .63 ± 2 .05 0.43 ± 0.08 0 .51 ± 0 .21 0.41 ± 0.08
Data shown are means ± SEM.
Figure 3 Total number of spermatozoa (× 10
3) released by males administered LHRHa (n = 10), AVT (n = 7) and AVT + LHRHa (n = 7)
over a 12 h sampling period. Data shown are untransformed mean ± SEM. Letters displayed are the result of a Tukey Kramer HSD post-hoc
test of Log10 (× +1) transformed data. Treatments that share a letter are not significantly different from each other.
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LHRHa with metoclopramide was shown to be effective
in increasing spawning rates of four American frog spe-
cies in captivity [18]. The use of dopamine antagonists
may therefore be a useful tool in improving the sper-
miation response of P. guentheri in future ART research.
Effect of LHRHa and AVT on spermiation response
T h er e s p o n s eo fP. guentheri to the administration of
LHRHa, AVT, and LHRHa in combination with AVT,
clearly showed that spermiation is most effectively
induced by LHRHa alone. The administration of AVT
has been shown to exert a positive effect on sperm
deposition in newts [21,23]. However, contrary to the
study by Moore et al. [23], the concomitant administra-
tion of AVT with LHRHa in P. guentheri did not
improve the spermiation response, and instead had an
inhibitory effect. The inhibition of gonadal activity by
AVT has also been reported in other vertebrate taxa,
including reptiles and mammals [34-37]. Additionally,
Yamashita et al. [38] discovered that the mechanism
underlying the antigonadal action of AVT in the dog
involved the AVT-induced suppression of LH release by
the anterior pituitary. Their study showed that AVT
administered prior to LHRH inhibited testicular activity,
but that AVT did not affect testicular activity when
administered prior to human chorionic gonadotropin
(hCG). The reproductive hormone hCG acts by mimick-
ing LH and therefore has the ability to bypass the inhi-
bitory effect of AVT on LH secretion and acts directly
o nt h eg o n a d s .T h ei n h i b i t o r ye f f e c to fA V To ns p e r -
miation reported in this study may be a result of the use
of AVT in combination with LHRHa. Future anuran
spermiation studies may benefit from administering
AVT in combination with hCG instead of LHRHa, or by
delaying the administration of AVT so that LHRHa can
first induce its effect on the gonads.
Conclusion
This study showed that LHRHa is highly effective at
inducing spermiation in the Günther’sT o a d l e t ,P.
guentheri. The maximal number of spermatozoa were
expelled in response to the administration of 2 μg/g
LHRHa, above all other doses trialled (0, 1, 4, or
8 μg/g). The concomitant administration of LHRHa
with AVT did not improve the spermiation response
and instead inhibited the expulsion of spermatozoa. The
hormone protocols used induced the release of sperma-
tozoa of lower sperm viability than those reported in
studies of other anuran species. The comparatively low
sperm viability reported in this study may be a conse-
quence of the collection latency period during which
spermatozoa remained in the cloaca, or may indicate
there was incomplete spermatogenesis prior to
spermiation. The refinement of current spermiation
protocols to improve sperm viability should be priori-
tized in future research developing artificial reproduc-
tion in P. guentheri.
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